Literature DB >> 24447412

Facilitating women's access to misoprostol through community-based advocacy in Kenya and Tanzania.

Francine Coeytaux1, Leila Hessini2, Nondo Ejano3, Albert Obbuyi4, Monica Oguttu5, Joachim Osur6, Kristen Shuken7.   

Abstract

OBJECTIVE: To explore the feasibility of educating communities about gynecologic uses for misoprostol at the community level through community-based organizations in countries with restrictive abortion laws.
METHODS: In 2012, the Public Health Institute and Ipas conducted an operations research study, providing small grants to 28 community-based organizations in Kenya and Tanzania to disseminate information on the correct use of misoprostol for both abortion and postpartum hemorrhage. These groups were connected to pharmacies selling misoprostol. The primary outcomes of the intervention were reports from the community-based organizations regarding the health education strategies that they had developed and implemented to educate their communities.
RESULTS: The groups developed numerous creative strategies to reach diverse audiences and ensure access to misoprostol pills. Given the restrictive environment, the groups attributed their success to having addressed the use of misoprostol for both indications (abortion and postpartum hemorrhage) and to using a harm reduction approach to frame the advocacy.
CONCLUSION: This initiative proves that, even where abortion is legally restricted and socially stigmatized, community-based organizations can publicly and openly share information about misoprostol and refer it to women by using innovative and effective strategies, without political backlash. Furthermore, it shows that communities are eager for this information.
Copyright © 2014 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Abortion; Advocacy; Hemorrhage; Misoprostol; Pharmacy access; Postpartum

Mesh:

Substances:

Year:  2014        PMID: 24447412     DOI: 10.1016/j.ijgo.2013.10.004

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  7 in total

1.  Oral health services within community-based organizations for young children with special health care needs.

Authors:  Stephanie Cruz; Donald L Chi; Colleen E Huebner
Journal:  Spec Care Dentist       Date:  2016-03-29

Review 2.  Reducing the harms of unsafe abortion: a systematic review of the safety, effectiveness and acceptability of harm reduction counselling for pregnant persons seeking induced abortion.

Authors:  Bianca Maria Stifani; Roopan Gill; Caron Rahn Kim
Journal:  BMJ Sex Reprod Health       Date:  2022-01-11

3.  Challenges in the abortion supply chain: a call to action for evaluation research.

Authors:  Ghazaleh Samandari; Nathalie Kapp; Christopher Hamon; Allison Campbell
Journal:  Reprod Health       Date:  2021-01-20       Impact factor: 3.223

4.  How, when and where? A systematic review on abortion decision making in legally restricted settings in sub-Saharan Africa, Latin America, and the Caribbean.

Authors:  Laura Hinson; Anam M Bhatti; Meroji Sebany; Suzanne O Bell; Mara Steinhaus; Claire Twose; Chimaraoke Izugbara
Journal:  BMC Womens Health       Date:  2022-10-10       Impact factor: 2.742

5.  Medical abortion offered in pharmacy versus clinic-based settings.

Authors:  Maria I Rodriguez; Alison Edelman; Alyssa Hersh; Pragya Gartoulla; Jillian Henderson
Journal:  Cochrane Database Syst Rev       Date:  2021-06-11

6.  Women's experiences with unplanned pregnancy and abortion in Kenya: A qualitative study.

Authors:  Ruvani T Jayaweera; Felistah Mbithe Ngui; Kelli Stidham Hall; Caitlin Gerdts
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

7.  Scaling up interventions: findings and lessons learned from an external evaluation of Niger's National Initiative to reduce postpartum hemorrhage.

Authors:  Meighan Mary; Ayisha Diop; Wendy R Sheldon; Aichatou Yenikoye; Beverly Winikoff
Journal:  BMC Pregnancy Childbirth       Date:  2019-10-24       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.